The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRbg Holdings Regulatory News (RBGP)

Share Price Information for Rbg Holdings (RBGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.75
Bid: 8.50
Ask: 9.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.882%)
Open: 8.75
High: 8.75
Low: 8.75
Prev. Close: 8.75
RBGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LionFish - first successful litigation investment

20 Apr 2021 08:00

RNS Number : 9666V
RBG Holdings PLC
20 April 2021
 

20 April 2021

 

RBG Holdings plc

("RBG" or the "Group")

 

LionFish records first successful litigation investment

 

RBG Holdings plc (AIM: RBGP), the professional services group, is pleased to announce that LionFish Litigation Finance Limited ("LionFish") has recorded its first successful litigation investment since its launch.

 

In May 2020, RBG launched LionFish as a new player in the third-party litigation funding market, investing in cases run by law firms other than the Group's own, Rosenblatt Limited ("RBL"). LionFish is led by experienced Managing Director, Tets Ishikawa.

 

While the return is not material to the Group's forecast financial results, the successful investment provides a gross two times money return over and above invested cash and confirms that LionFish can deliver significant returns from its portfolio of investments.

 

Part of the Group's approach to litigation finance is to sell a percentage of its participation rights in the cases LionFish invests in, and this reported return is pre-investor payout.

 

As of 31 December 2020, LionFish has received 240 enquiries for finance, and seven cases have been invested in. LionFish has made a cash investment of £1.8 million across the seven cases, with a total capital commitment of £4.9 million. The expected average investment duration is around two years.

 

Nicola Foulston, CEO, RBG Holdings plc, said: "This is a proof-of-concept moment for our litigation finance strategy. The success of this first investment demonstrates that LionFish can make a significant contribution to the Group, but also deliver substantial returns to investors who acquire participation rights. We believe this will make LionFish an even more attractive prospect. Congratulations to Tets and the LionFish team."

 

 

Enquiries:

 

RBG Holdings plc

Nicola Foulston, CEO

 

 Via SEC Newgate

 

N+1 Singer (Nomad and Broker)

Shaun Dobson / Alex Bond (Corporate Finance)

Tom Salvesen (Corporate Broking)

Tel: +44 (0)20 7496 3000

SEC Newgate (for media enquiries)

Robin Tozer/Tom Carnegie

Tel: +44 (0)7540 106366; rbg@secnewgate.co.uk

 

About RBG Holdings plc

RBG Holdings plc is a professional services group, which includes one of the UK's pioneering law firms, Rosenblatt Limited ("RBL"), which is a leader in dispute resolution.

 

RBL provides a range of legal services to its diversified client base, which includes companies, banks, entrepreneurs, and individuals. Complementing this is the Firm's increasingly international footprint, advising on complex cross-jurisdictional matters. RBL's practice areas include banking & finance, competition & regulatory, corporate, dispute resolution, employment, financial crime, financial services, insolvency & financial restructuring IP/technology/media, real estate, serious & general crime, tax resolution, and white-collar crime.

 

The Group also provides litigation finance in selected cases through a separate arm, LionFish Litigation Finance (UK) Limited ("LionFish"). LionFish finances litigation matters being run by other solicitors in return for a significant return on the outcome of those cases. As such, the Group has two types of litigation assets - RBL's own client matters, and litigation matters run by third-party solicitors. LionFish is positioned to be a unique, alternative provider to the traditional litigation funders.

 

The Group also owns Convex Capital Limited ("Convex Capital"), a specialist sell-side corporate finance boutique, based in Manchester. Convex Capital is entirely focussed on helping companies, particularly owner-managed and entrepreneurial businesses, realise their value through sales to large corporates. Convex Capital identifies and proactively targets firms that it believes represent attractive acquisition opportunities.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFBLBLFZLBBBV
Date   Source Headline
8th May 20245:39 pmRNSHolding(s) in Company
2nd May 20244:53 pmRNSAnnual Report and Accounts and Notice of AGM
30th Apr 20247:00 amRNSResults for the Year Ended 31 December 2023
8th Apr 20243:37 pmRNSHolding(s) in Company
8th Apr 202412:43 pmRNSHolding(s) in Company
4th Apr 20247:00 amRNSNotice of Results & Investor Presentation
28th Mar 20241:00 pmRNSDisposal of Convex Capital & Directorate Change
14th Mar 20242:01 pmRNSDirector/PDMR Dealings
12th Mar 202411:50 amRNSResult of General Meeting
12th Mar 20247:00 amRNSAIM Rule 17 Schedule Two (g) Update
11th Mar 20247:00 amRNSResult of Retail Offer
28th Feb 202411:03 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSRetail Offer
22nd Feb 20243:33 pmRNSResult of Placing and Subscription
22nd Feb 20247:00 amRNSProposed Fundraising and Notice of GM
10th Jan 20241:56 pmRNSHolding(s) in Company
19th Dec 20235:24 pmRNSHolding(s) in Company
18th Dec 20237:00 amRNSTrading Update
11th Dec 20237:00 amRNSRefinancing and Convex Capital Update
29th Nov 20237:00 amRNSDirectorate Change
31st Oct 20237:00 amRNSConvex Capital Update
30th Oct 20237:00 amRNSStatement Confirming Settlement
5th Oct 20235:40 pmRNSHolding(s) in Company
3rd Oct 20235:30 pmRNSHolding(s) in Company
2nd Oct 20236:21 pmRNSPDMR / PCA Dealing
28th Sep 20237:00 amRNSUnaudited Interim Results
11th Sep 20237:00 amRNSNotice of Results
31st Jul 202312:42 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSIan Rosenblatt appointed as an Executive Director
27th Jul 20237:00 amRNSPre-close Trading and Business Update
26th Jul 20234:13 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSSale of LionFish Litigation Finance Limited
27th Jun 20237:00 amRNSDirectorate Change
22nd Jun 202311:11 amRNSResult of AGM & Directorate Change
23rd May 20239:07 amRNSNotice of AGM and Dividend
17th May 20233:28 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSResults for the year ended 31 Dec 2022
18th Apr 20237:00 amRNSNotice of Investor Presentation
3rd Mar 202312:44 pmRNSCorrection: Board Changes and Notice of Results
3rd Mar 202312:18 pmRNSBoard Changes and Notice of Results
31st Jan 20237:00 amRNSBoard Changes & Pre-Close Trading Update
3rd Jan 20237:00 amRNSDirectorate Changes
12th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20227:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 202211:05 amRNSSecond Price Monitoring Extn
5th Dec 202211:00 amRNSPrice Monitoring Extension
5th Dec 20229:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.